---
type: "Symbol"
title: "United Imaging Healthcare (688271.SH) — Community Discussions"
description: "Community discussions about this stock, including analyst opinions, earnings analysis, and investment strategies from verified financial professionals and active investors."
locale: "en"
url: "https://longbridge.com/en/quote/688271.SH/topics.md"
symbol: "688271.SH"
parent: "https://longbridge.com/en/quote/688271.SH.md"
count: 12
datetime: "2026-03-13T08:41:13.042Z"
locales:
  - [en](https://longbridge.com/en/quote/688271.SH/topics.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688271.SH/topics.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688271.SH/topics.md)
---

# United Imaging Healthcare (688271.SH) — Community Discussions

### [Reduced holdings by 1.82 billion! United Imaging Healthcare employee shareholding platform cashed out a total of 2.71 billion in two years](https://longbridge.com/en/topics/36835540.md)

- Author: [侃见财经](https://longbridge.com/en/profiles/3206955.md)
- Datetime: 2025-12-02T00:54:09.000Z
- Comments: 0
- The cycle of the medical device industry has not yet arrived, and some shareholders of leading companies have chosen to cash out first. Recently, United Imaging Healthcare, known as the "King of D

### [Otis Worldwide Corp 4000 字深度研报](https://longbridge.com/en/topics/35964942.md)

- Author: [巴芒的徒孙](https://longbridge.com/en/profiles/23717031.md)
- Datetime: 2025-11-04T08:48:21.000Z
- Comments: 0
- $Otis Worldwide - WI(OTIS.US)$United Imaging Healthcare(688271.SH) researched Otis Worldwide, whose core relies on the high-stickiness services of the elevator aftermarket (maintenance + retrofitting)

### [Otis Worldwide Corp 4000 字深度研报](https://longbridge.com/en/topics/35776489.md)

- Author: [巴芒的徒孙](https://longbridge.com/en/profiles/23717031.md)
- Datetime: 2025-10-30T06:25:16.000Z
- Comments: 0
- $Otis Worldwide - WI(OTIS.US)$United Imaging Healthcare(688271.SH) Recently studied Otis, the biggest takeaway is its "Equipment Lock Service" cash flow model is very stable, but the high debt

### [China Medical Technology ETF (2841) benefits from positive industry development.](https://longbridge.com/en/topics/33654285.md)

- Author: [Global X ETFs Hong Kong](https://longbridge.com/en/profiles/21653233.md)
- Datetime: 2025-09-05T01:46:17.000Z
- Comments: 0
- [For Hong Kong investors' reference only] China's medical technology industry has seen growth over the past few months, driven by several positive factors: 1) Recovery in hospital equipment procuremen

### [Leading medical imaging operator Yimai Sunshine IPO, healthcare reform and population aging will be the guarantee for the company's continued growth.](https://longbridge.com/en/topics/21561987.md)

- Author: [明大教主](https://longbridge.com/en/profiles/6871671.md)
- Datetime: 2024-06-03T01:03:25.000Z
- Comments: 0
- Preface: Investment requires "following the tide of the times." Beyond monetary policy and economic data, industry cycles are one of the more crucial "tides" in investing. For example,

### [北京协和医院公布了一份采购清单，其中包括了国产的 3.0T、5.0T 核磁共振设备，这对于一直以来采…](https://longbridge.com/en/topics/6035726.md)

- Author: [股友DgPbNy](https://longbridge.com/en/profiles/7200471.md)
- Datetime: 2023-05-13T09:33:10.000Z
- Comments: 1
- 北京协和医院公布了一份采购清单，其中包括了国产的 3.0T、5.0T 核磁共振设备，这对于一直以来采购国外高端医疗设备的国内排名第一的三甲医院来说可谓是一次大胆的尝试。不过，这也让一些外企开始警觉，他们不再像以前那样坐以待毙。为了改变之前备受制约的局面，中科院和国内多家科研单位开始合作研发核心零部件，并且已经取得了 124 项专利。联影医疗、东软集团、宽腾医疗等国内企业也相继推出国产核磁共振设备。

**Comments:**

- **元首交易员镗缸仔之父 · 2024-09-26T16:16:31.000Z**: 中山一院毫无疑问又采购西门子的

### [布局 10 年长赛道，AI+ 医学影像大蓝海](https://longbridge.com/en/topics/4706359.md)

- Author: [药械Talks](https://longbridge.com/en/profiles/6059509.md)
- Datetime: 2023-04-03T02:48:47.000Z
- Comments: 0
- 本文主要分析 AI 在医学影像行业的应用，涉及的上市公司包括：$United Imaging Healthcare(688271.SH) 、$Lepu Medical(300003.SZ) 、万东医疗、润达医疗、安必平、$AIRDOC-B(02251.HK) （港股）AI 在医学影像领域的作用，体现在提升了诊疗效率和准确率。借助图像识别和深度学习，AI 适用于超声、X 线、内镜、CT、MRI（磁共

### [科创板医药板块年度盘点：八成企业股价下跌，2 家企业市值超千亿](https://longbridge.com/en/topics/3950087.md)

- Author: [药械Talks](https://longbridge.com/en/profiles/6059509.md)
- Datetime: 2023-02-10T01:36:17.000Z
- Comments: 0
- 众所周知，科创板在医药类企业的融资中承担了重要的角色。自 2019 年 6 月开板以来，科创板市场已经迎来了上百家医药类企业上市融资，期间也造就了许多千亿市值企业。根据同花顺数据显示，截至 2022 年 12 月 30 日，科创板共有 102 家医药相关企业，其中有 23 家企业于 2022 年上市，主要涉及医疗器械、创新药及相关产业链。市值方面，2022 年有 6 家企业市值超过 300 亿元.

### [超级周，我们有没有出路？再聊聊美农业板块、内房、医疗器械](https://longbridge.com/en/topics/3521108.md)

- Author: [说财经](https://longbridge.com/en/profiles/8322226.md)
- Datetime: 2022-10-11T06:25:40.000Z
- Comments: 0
- 恒指跌到大家哇哇叫，很难想象 700 去到 250，美团也领跌恒生科技指数，市场难道只有沽空才能赚到钱？都有不少悬而未决的问题，比如巴菲特为什么拼命买油股？俄乌升级，我们还能选农业股？迈瑞、招商蛇口，还能涨？A 股更刺激？今日党天楚带着他的观察，同大家细说。节目虽然走长视频，还是这句话，大家可以根据时间轴，拉到自己有兴趣的地方：P0:07 節目開始/恒指 2:24 美團 (3690) 跌得最慘..

### [突破巨头封锁！稀缺、顶级的国产高端仪器龙头，比联影的潜力还要大](https://longbridge.com/en/topics/3428726.md)

- Author: [药械Talks](https://longbridge.com/en/profiles/6059509.md)
- Datetime: 2022-09-09T01:46:07.000Z
- Comments: 0
- 在高端医疗器械领域，背负着国产化替代重任的不只有联影医疗，还有$MGI(688114.SH) 。虽然两家公司分属不同的业务领域，但都因掌握核心技术、打破跨国巨头垄断而吸引了资本市场的极大关注。作为国产医学影像龙头的联影医疗已经登陆科创板市场，并获得了资本市场的肯定，总市值超 1500 亿元，而作为基因测序仪龙头的华大智造科创板 IPO 注册于今年 7 月获得了证监会同意，将在 8 月 31 日招股

### [突破巨头封锁！稀缺、顶级的国产高端仪器龙头，比联影的潜力还要大](https://longbridge.com/en/topics/3382146.md)

- Author: [药械Talks](https://longbridge.com/en/profiles/6059509.md)
- Datetime: 2022-08-28T13:48:32.000Z
- Comments: 0
- 在高端医疗器械领域，背负着国产化替代重任的不只有联影医疗，还有华大智造。虽然两家公司分属不同的业务领域，但都因掌握核心技术、打破跨国巨头垄断而吸引了资本市场的极大关注。作为国产医学影像龙头的$United Imaging Healthcare(688271.SH) 已经登陆科创板市场，并获得了资本市场的肯定，总市值超 1500 亿元，而作为基因测序仪龙头的华大智造科创板 IPO 注册于今年 7 月

### [如何规避风险？活用市场情绪](https://longbridge.com/en/topics/4118989.md)

- Author: [实战教学](https://longbridge.com/en/profiles/9920524.md)
- Datetime: 2022-08-24T07:22:04.000Z
- Comments: 0
- 近期华为应改变思路和经营方针，从追求规模转向追求利润和现金流，保证渡过未来三年的危机。“把活下来作为最主要纲领，边缘业务全线收缩和关闭引发市场担忧

## References

- [United Imaging Healthcare (688271.SH)](https://longbridge.com/en/quote/688271.SH.md)


> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/688271.SH/topics.md) | [繁體中文](https://longbridge.com/zh-HK/quote/688271.SH/topics.md)